Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Effects of Mexican Ganoderma lucidum extracts on liver, kidney, and the gut microbiota of Wistar rats: A repeated dose oral toxicity study. β
Go to Publication β
PloS one (PLoS One ) Vol: 18 Issue 4 Pages: e0283605 Pub: 2023 Epub: 2023 Apr 6 Authors Meneses ME , Martínez-Carrera D , González-Ibáñez L , Torres N , Sánchez-Tapia M , Márquez-Mota CC , Rendón G , Mitzi V , Morales A , Tello-Salgado I , Tovar AR , |
|
|
Effects of Mexican Ganoderma lucidum extracts on liver, kidney, and the gut microbiota of Wistar rats: A repeated dose oral toxicity study. β
Go to Publication β
PloS one (PLoS One ) Vol: 18 Issue 4 Pages: e0283605 Pub: 2023 Epub: 2023 Apr 6 Authors Meneses ME , Martínez-Carrera D , González-Ibáñez L , Torres N , Sánchez-Tapia M , Márquez-Mota CC , Rendón G , Mitzi V , Morales A , Tello-Salgado I , Tovar AR , |
|
|
A polysaccharide isolated from Ganoderma lucidum ameliorates hyperglycemia through modulating gut microbiota in type 2 diabetic mice. β
Go to Publication β
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 197 Issue Pages: 23-38 Pub: 2022 Feb 1 Epub: 2021 Dec 15 Authors Shao W , Xiao C , Yong T , Zhang Y , Hu H , Xie T , Liu R , Huang L , Li X , Xie Y , Zhang J , Chen S , Cai M , Chen D , Liu Y , Gao X , Wu Q , |
|
|
Intake of Ganoderma lucidum polysaccharides reverses the disturbed gut microbiota and metabolism in type 2 diabetic rats. β
Go to Publication β
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 155 Issue Pages: 890-902 Pub: 2020 Jul 15 Epub: 2019 Nov 9 Authors Chen M , Xiao D , Liu W , Song Y , Zou B , Li L , Li P , Cai Y , Liu D , Liao Q , Xie Z , |
|
|
Intake of Ganoderma lucidum polysaccharides reverses the disturbed gut microbiota and metabolism in type 2 diabetic rats. β
Go to Publication β
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 155 Issue Pages: 890-902 Pub: 2020 Jul 15 Epub: 2019 Nov 9 Authors Chen M , Xiao D , Liu W , Song Y , Zou B , Li L , Li P , Cai Y , Liu D , Liao Q , Xie Z , |
|
|
Intake of Ganoderma lucidum polysaccharides reverses the disturbed gut microbiota and metabolism in type 2 diabetic rats. β
Go to Publication β
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 155 Issue Pages: 890-902 Pub: 2020 Jul 15 Epub: 2019 Nov 9 Authors Chen M , Xiao D , Liu W , Song Y , Zou B , Li L , Li P , Cai Y , Liu D , Liao Q , Xie Z , |
|
|
Effects of Ganoderma lucidum polysaccharides on chronic pancreatitis and intestinal microbiota in mice. β
Go to Publication β
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 93 Issue Pt A Pages: 904-912 Pub: 2016 Dec Epub: 2016 Sep 9 Authors Li K , Zhuo C , Teng C , Yu S , Wang X , Hu Y , Ren G , Yu M , Qu J , |
|
|
Effects of Ganoderma lucidum polysaccharides on chronic pancreatitis and intestinal microbiota in mice. β
Go to Publication β
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 93 Issue Pt A Pages: 904-912 Pub: 2016 Dec Epub: 2016 Sep 9 Authors Li K , Zhuo C , Teng C , Yu S , Wang X , Hu Y , Ren G , Yu M , Qu J , |
|
|
Effects of Ganoderma lucidum polysaccharides on chronic pancreatitis and intestinal microbiota in mice. β
Go to Publication β
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 93 Issue Pt A Pages: 904-912 Pub: 2016 Dec Epub: 2016 Sep 9 Authors Li K , Zhuo C , Teng C , Yu S , Wang X , Hu Y , Ren G , Yu M , Qu J , |
|
|
Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. β
Go to Publication β
Nature communications (Nat Commun ) Vol: 6 Issue Pages: 7489 Pub: 2015 Jun 23 Epub: 2015 Jun 23 Authors Chang CJ , Lin CS , Lu CC , Martel J , Ko YF , Ojcius DM , Tseng SF , Wu TR , Chen YY , Young JD , Lai HC , |
|
|
Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. β
Go to Publication β
Nature communications (Nat Commun ) Vol: 6 Issue Pages: 7489 Pub: 2015 Jun 23 Epub: 2015 Jun 23 Authors Chang CJ , Lin CS , Lu CC , Martel J , Ko YF , Ojcius DM , Tseng SF , Wu TR , Chen YY , Young JD , Lai HC , |
|
|
Regulatory effect of Ganoderma lucidum and its active components on gut flora in diseases. β
Go to Publication β
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1362479 Pub: 2024 Epub: 2024 Mar 18 Authors Qin X , Fang Z , Zhang J , Zhao W , Zheng N , Wang X , |
|
|
Anti-breast Cancer Enhancement of a Polysaccharide From Spore of Ganoderma lucidum With Paclitaxel: Suppression on Tumor Metabolism With Gut Microbiota Reshaping. β
Go to Publication β
Frontiers in microbiology (Front Microbiol ) Vol: 9 Issue Pages: 3099 Pub: 2018 Epub: 2018 Dec 17 Authors Su J , Li D , Chen Q , Li M , Su L , Luo T , Liang D , Lai G , Shuai O , Jiao C , Wu Q , Xie Y , Zhou X , |
|
|
Combined Ganoderma lucidum polysaccharide and ciprofloxacin therapy alleviates Salmonella enterica infection, protects the intestinal barrier, and regulates gut microbiota. β
Go to Publication β
Food & function (Food Funct ) Vol: 14 Issue 15 Pages: 6896-6913 Pub: 2023 Jul 31 Epub: 2023 Jul 31 Authors Li M , Yu L , Zhai Q , Chu C , Wang S , Zhao J , Zhang H , Tian F , Chen W , |
|
|
Combined Ganoderma lucidum polysaccharide and ciprofloxacin therapy alleviates Salmonella enterica infection, protects the intestinal barrier, and regulates gut microbiota. β
Go to Publication β
Food & function (Food Funct ) Vol: 14 Issue 15 Pages: 6896-6913 Pub: 2023 Jul 31 Epub: 2023 Jul 31 Authors Li M , Yu L , Zhai Q , Chu C , Wang S , Zhao J , Zhang H , Tian F , Chen W , |
|
|
Combined Ganoderma lucidum polysaccharide and ciprofloxacin therapy alleviates Salmonella enterica infection, protects the intestinal barrier, and regulates gut microbiota. β
Go to Publication β
Food & function (Food Funct ) Vol: 14 Issue 15 Pages: 6896-6913 Pub: 2023 Jul 31 Epub: 2023 Jul 31 Authors Li M , Yu L , Zhai Q , Chu C , Wang S , Zhao J , Zhang H , Tian F , Chen W , |
|
|
Combined Ganoderma lucidum polysaccharide and ciprofloxacin therapy alleviates Salmonella enterica infection, protects the intestinal barrier, and regulates gut microbiota. β
Go to Publication β
Food & function (Food Funct ) Vol: 14 Issue 15 Pages: 6896-6913 Pub: 2023 Jul 31 Epub: 2023 Jul 31 Authors Li M , Yu L , Zhai Q , Chu C , Wang S , Zhao J , Zhang H , Tian F , Chen W , |
|
|
Combined Ganoderma lucidum polysaccharide and ciprofloxacin therapy alleviates Salmonella enterica infection, protects the intestinal barrier, and regulates gut microbiota. β
Go to Publication β
Food & function (Food Funct ) Vol: 14 Issue 15 Pages: 6896-6913 Pub: 2023 Jul 31 Epub: 2023 Jul 31 Authors Li M , Yu L , Zhai Q , Chu C , Wang S , Zhao J , Zhang H , Tian F , Chen W , |
|
|
Modulation of gut microbiota and lipid metabolism in rats fed high-fat diets by Ganoderma lucidum triterpenoids. β
Go to Publication β
Current research in food science (Curr Res Food Sci ) Vol: 6 Issue Pages: 100427 Pub: 2023 Epub: 2022 Dec 27 Authors Tong A , Wu W , Chen Z , Wen J , Jia R , Liu B , Cao H , Zhao C , |
|
|
Polysaccharides of Sporoderm-Broken Spore of Ganoderma lucidum Modulate Adaptive Immune Function via Gut Microbiota Regulation. β
Go to Publication β
Evidence-based complementary and alternative medicine : eCAM (Evid Based Complement Alternat Med ) Vol: 2021 Issue Pages: 8842062 Pub: 2021 Epub: 2021 Mar 23 Authors Su L , Li D , Su J , Zhang E , Chen S , Zheng C , Luo T , Li M , Chen X , Huang G , Xie Y , Li S , |
|
|
Ganoderma lucidum polysaccharide improves rat DSS-induced colitis by altering cecal microbiota and gene expression of colonic epithelial cells. β
Go to Publication β
Food & nutrition research (Food Nutr Res ) Vol: 63 Issue Pages: Pub: 2019 Epub: 2019 Feb 12 Authors Xie J , Liu Y , Chen B , Zhang G , Ou S , Luo J , Peng X , |
|
|
Anti-breast Cancer Enhancement of a Polysaccharide From Spore of Ganoderma lucidum With Paclitaxel: Suppression on Tumor Metabolism With Gut Microbiota Reshaping. β
Go to Publication β
Frontiers in microbiology (Front Microbiol ) Vol: 9 Issue Pages: 3099 Pub: 2018 Epub: 2018 Dec 17 Authors Su J , Li D , Chen Q , Li M , Su L , Luo T , Liang D , Lai G , Shuai O , Jiao C , Wu Q , Xie Y , Zhou X , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
